Fusobacterium nucleatum , immune responses, and metastatic organ diversity in colorectal cancer liver metastasis
Cancer Science · 2024-10 · 115 (10) · 3248-3255
DOI: 10.1111/cas.16315 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 14.08.2024. Verfasst von Yasuyuki Shigematsu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. Hauptthemen laut MEDLINE: Fusobacterium nucleatum, Colorectal Neoplasms, Liver Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science, Yakult Bio-Science Foundation.
Abstract (Originalsprache)
The presence of Fusobacterium nucleatum is associated with an immunosuppressive tumor immune microenvironment (TIM) in primary colorectal cancer (CRC), contributing to tumor progression. Its persistence in CRC liver metastasis tissues raises questions about its role in modulating local and systemic immune responses and influencing recurrence patterns. This retrospective cohort study of 218 patients with CRC liver metastasis investigated the association of F. nucleatum in CRC liver metastasis tissues with systemic inflammation, TIM alterations, and the number of metastatic organs involved in recurrence. Two‐step polymerase chain reaction (PCR), including digital PCR, detected F. nucleatum in 42% (92/218) of fresh‐frozen specimens of CRC liver metastases. Compared with the F. nucleatum‐ none group, the F. nucleatum‐ high group showed higher C‐reactive protein levels (0.82 vs. 0.22 mg/dL; P trend = 0.02), lower numbers of CD8 + cells (33.2 vs. 65.3 cells/mm 2 ; P trend = 0.04) and FOXP3 + cells (11.3 vs. 21.7 cells/mm 2 ; P trend = 0.01) in the TIM, and a greater number of metastatic organs involved in recurrence (1.6 vs. 1.1; p < 0.001). The presence of F. nucleatum in CRC liver metastasis tissues was associated with increased systemic inflammation, TIM alterations, and a greater number of metastatic organs involved in recurrence. These findings suggest a potential contribution of F. nucleatum to the metastatic propensity of CRC cells and could inform future research to enhance understanding of the interaction between tumor, host, and microbes in the metastatic process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
- Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
- Department of Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
- Department of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan.
- Graduate School of Engineering, Chiba Institute of Technology, Chiba, Japan.
- Division of Tumor Pathology, Jichi Medical University, Tochigi, Japan.
ORCID-Profile: Yasuyuki Shigematsu, Kengo Takeuchi, Kentaro Inamura
Förderung
- Japan Society for the Promotion of Science
- Yakult Bio-Science Foundation
Zitieren
APA
Shigematsu, Y., Saito, R., Amori, G., Kanda, H., Takahashi, Y., Takeuchi, K., Takahashi, S., & Inamura, K. (2024). Fusobacterium nucleatum , immune responses, and metastatic organ diversity in colorectal cancer liver metastasis. Cancer Science, 115(10), 3248-3255. https://doi.org/10.1111/cas.16315
Vancouver
Shigematsu Y, Saito R, Amori G, Kanda H, Takahashi Y, Takeuchi K, et al. Fusobacterium nucleatum , immune responses, and metastatic organ diversity in colorectal cancer liver metastasis. Cancer Science. 2024;115(10):3248-3255. doi:10.1111/cas.16315
BibTeX
@article{Shigematsu2024,
author = {Shigematsu, Yasuyuki and Saito, Rumiko and Amori, Gulanbar and Kanda, Hiroaki and Takahashi, Yu and Takeuchi, Kengo and Takahashi, Shunji and Inamura, Kentaro},
title = {Fusobacterium nucleatum , immune responses, and metastatic organ diversity in colorectal cancer liver metastasis},
journal = {Cancer Science},
year = {2024},
volume = {115},
number = {10},
pages = {3248--3255},
doi = {10.1111/cas.16315}
}
EUVIMED